Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, and the Aarhus Convention on Access to Information, Public Participation in Decision-Making and Access to Justice in Environmental Matters as implemented by Regulation (EC) No 1367/2006 and Directive 2003/4/EC, we are requesting documents concerning the following subject:
All emergency authorisations since 29 May 2018 for the three substances thiamethoxam, imidacloprid and clothianidin, of which the use was restricted by the regulations 2018/783, 2018/784 and 2018/785 of 29 May 2018.
We are requesting all internal and external documents - including but not limited to emails, communication, presentations, agendas, attendance lists and minutes of meetings - that the EFSA holds about this subject. We are also looking for all internal communication and communications with, and documents about this subject that were exchanged with, for example but not limited to:
- All 27 EU Member States and the former EU Member State United Kingdom
- SG of the EU Commission
- The European Food Safety Authority
- DG Health and Food Safety
- DG Environment
- DG Agriculture
- The Council of the European Union
- The European Council
- The Standing Committee on Plants, Animals, Food and Feed (SCoPAFF)
- The European Parliament
- Crop protection companies like but not limited to Bayer, BASF, Syngenta and Corteva that use one of the three substances in their plant protection products
- Sugarbeet and sugar companies including but not limited to Tereos, Royal Cosun, SESVanderHave and other parties that represent their interest
- The European Crop Protection Association (ECPA), COPA-COGECA, CIBE and other organisations that represent their interests
- Any other private parties, including but not limited to law firms, lobbying firms and consultancy companies
We trust we will receive a reply within the legal period of fifteen working days. Should our requests be denied wholly or partially, please explain the denial or all deletions referring to specific exemptions in the regulation. We also expect the partial release of documents in case of partial exemption according to article 4.6.
Tim Luimes and Tomas Vanheste
The Investigative Desk (https://investigativedesk.com/)
1079 RH Amsterdam
Dear Mr. Luimes,
We are writing to you in relation to your application where you’ve requested the documents concerning all emergency authorisations since 29 May 2018 for the three substances thiamethoxam, imidacloprid and clothianidin, that were in the possession of the European Food Safety Authority (EFSA).
Given the fact that your demand concerns the documents held by the EFSA, your application will be registered and handled by this authority. Therefore, please note that your request for access to documents will be closed in DG TRADE.
TRADE Access to Documents Team